Listen "EP 124: Coronary Interventions and Evolving Technologies: The Year 2024 In Review with Dr Sukh Nijjer"
Episode Synopsis
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2024.
Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.
This episode focuses on recent developments in interventional cardiology, covering coronary interventions, new device technologies and challenging patient populations. Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials:
REDUCE-AMI
PREVENT
FAVOR III
ORBITA-COSMIC
DANGer SHOCK
SENIOR-RITA
NOTION 3
What are the most impactful cardiovascular trials of 2024? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?
Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.
This episode focuses on recent developments in interventional cardiology, covering coronary interventions, new device technologies and challenging patient populations. Drs Kalra and Nijjer share their perspectives and experiences, offering valuable insights, practical tips and considerations when interpreting this year’s most impactful trials:
REDUCE-AMI
PREVENT
FAVOR III
ORBITA-COSMIC
DANGer SHOCK
SENIOR-RITA
NOTION 3
What are the most impactful cardiovascular trials of 2024? How do Dr Kalra and Dr Nijjer integrate the latest information into their daily practices?
More episodes of the podcast Parallax by Ankur Kalra
EP 145: From NAFLD to MASLD: Unveiling the Cardiovascular Impact of Metabolic Liver Disease
27/10/2025
EP 142: The Psychology of Patient Care: Nudges, Gamification, and the Future of Cardiology
08/09/2025
EP 141: From EMPA-REG to Clinical Practice: Mastering SGLT2 Inhibitors in Modern Cardiology
26/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.